Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Kroger Co (KR) Price & Performance

Inovio Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Kroger Co — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M), while Kroger Co trades at $56 (market cap $34.60B). The key difference: Kroger Co is far larger — about 454.7× Inovio Pharmaceuticals Inc's market cap, and Kroger Co pays a 2.55% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

INOKR
Market Cap
$76.09M$34.60B
Sector
HealthConsumer Staples
52-Week High
$2.87$75.60
52-Week Low
$0.66$55.53
Enterprise Value
$47.10M$54.70B
Dividend Yield
2.55%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO

About Kroger Co

Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.

Read more on KR